期刊文献+

抑制生长因子受体连接蛋白-2表达对乳癌细胞生长的影响 被引量:5

Effect of inhibiting expression of growth factor receptor-bound protein-2 on proliferation of breast cancer cells
下载PDF
导出
摘要 目的进一步验证生长因子受体连接蛋白-2(Grb2)的表达在乳癌发展中的作用。方法应用脂质体转染技术将Grb2小干扰RNA(siRNA)转染至乳癌细胞SKBr3中,台盼蓝计数法测定存活细胞数,TUNEL技术和AnnexinⅤ/PI染色分析转染后细胞的凋亡,免疫细胞化学技术分析转染后细胞Grb2的表达。Western蛋白质印迹法测定Grb2、细胞外信号调节激酶(p42/44ERK)、磷酸化p42/44ERK(P-p42/44ERK)、原癌基因蛋白质c-akt(Akt)、磷酸化Akt(P-Akt)和STAT5转录因子表达的改变。流式细胞术检测细胞活化的半胱氨酸天冬氨酸蛋白酶(caspase)3的表达。结果台盼蓝计数法结果显示,转染Grb2siRNA可有效抑制SKBr3的生长。TUNEL实验显示,Grb2siRNA转染SKBr3细胞后,随着时间延长,凋亡细胞明显增加。AnnexinⅤ/PI测定结果亦提示,Grb2的抑制可明显诱导SKBr3细胞凋亡。转染48h后,SKBr3的活化caspase3表达水平由0.99%升至17.43%。免疫组化染色表明,Grb2siRNA转染细胞后,SKBr3细胞Grb2表达明显下降,由转染24h后的下降至转染72h后的+~-。Western蛋白质印迹分析证实,Grb2的抑制可导致SKBr3细胞P-p42/44ERK,P-Akt以及STAT5表达明显下降。P-p42ERK与p42ERK的相对吸光度值之比由未转染的(60±17)%下降至转染24h后的(38±13)%,及转染48h后的(21±8)%;P-p44ERK与p44ERK的相对吸光度值之比,由未转染时(104±16)%,分别下降至(49±13)%及(30±10)%;P-Akt与Akt的相对吸光度值之比由未转染的(40±6)%下降至(32±10)%和(15±4)%。与未转染组相比,转染24及48h后STAT5相对吸光度值分别下降为(64±6)%和(52±14)%。结论抑制Grb2的表达可抑制乳癌细胞生长并诱导细胞凋亡。 AIM To confirm the effect of growth factor receptor-bound protein-2 ( Grb2 ) inhibition on the advance of breast cancer. METHODS Grb2 small interference RNA (siRNA) was transfected to breast cancer cells (SKBr3) by Lipofectamine transfection system. Trypan blue exclusion assay was used to observe the inhibition of cell proliferation. The apoptosis of breast cancer cells induced by Grb2 siRNA was analyzed using TUNEL assay and Annexin V/PI staining. The expression of Grb2 in SKBr3 cells transfected with Grb2 siRNA was examined with immunocytochemistry. The expression of signal molecules including Grb2, extracellular signal-regulated kinase ( p42/44 ERK), phosphorylated ERK ( P-p42/ 44 ERK ), proto-oncogene proteins c-akt (Akt), phosphorylated Akt(P-Akt) and STAT 5 transcripition factor was evaluated by Western blot assay. Caspase-3 was examined by flow cytometry(FCM). RESULTS Trypan blue exclusion assay showed that Grb2 siRNA could inhibit the growth of SKBr3 cells significantly. TUNEL test demonstrated that the percentage of apoptotic cells increased greatly on SKBr3 cells transfected with Grb2 siRNA in a time-dependent manner. Annexin V/PI analysis also suggested that the inhibition of Grb2 lead to the apoptosis of SKBr3 cells obviously. After transfection for 48 h, the level of active caspase 3 of SKBr3 cells was up to 17.43% from 0.99%. Immunocytochemistry demonstrated that the expression of Grb2 decreased greatly in SKBr3 cells transfected with Grb2 siRNA, and the expression degree decreased from +++ (24 h after transfection) to + to - (72 h after transfection). Western Blot assay showed that the inhibition of Grb2 could decrease the level of phosphorylated ERK(including P-p42 and P-p44), P-Akt and STAT 5 transcription factor of SKBr3 cells significantly. The ratio of relative band density of P-p42 ERK vs p42 ERK was respec-tively(60 ±17 ) % for without transfection, ( 38 ± 13 )% at 24 h after transfection, and (21± 8 ) % at 48 h after transfection ; the ratio of P-p44 ERK vs p44 ERK was respectively (104 ±16 )% for without transfection, (49±13) % at 24 h after transfection, and (30 ±10) % at 48 h after transfection; the ratio of P- Akt vs Akt was respectively (40 ± 6 ) % for without transfection, (32 ±10)% at 24 h after transfection, and (15±4)% at 48 h after transfection; the relative band density of STAT 5 transcription factor decreased to ( 64± 6 ) % at 24 h after transfection and ( 52 ± 14 ) % at 48 h after transfection, compared to that with- out transfection. CONCLUSION Inhibition of Grb2 expression has inhibitory effect on breast cancer cells and induces apoptosis.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2008年第1期55-62,共8页 Chinese Journal of Pharmacology and Toxicology
基金 福建省医学创新课题资助项目(2007-CXB-1)~~
关键词 受体 生长因子 RNA干扰 乳腺肿瘤 细胞凋亡 receptors, growth factor RNA interference breast neoplasmas apoptosis
  • 相关文献

参考文献17

  • 1Zhang Z, Li M, Rayburn ER, Hill DL, Zhang R, Wang H. Oncogenes as novel targets for cancer therapy (part I ) : growth factors and protein tyrosine kinases[J]. Am J Pharmacogenomics, 2005, 5(3) :173 - 190.
  • 2Broxterman HI, Georgopapadakou NH. New cancer therapeutics: target-specific in, cytotoxics out [ J ]? Drug Resist Updat, 2004, 7(2) :79 -87.
  • 3Janes PW, Daly R J, deFazio A, Sutherland RL. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2 [ J ]. Oncogene, 1994, 9(12) :3601 - 3608.
  • 4Simon JA, Schreiber SL. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions[J]. Chem Biol, 1995, 2(1 ) :53 -60.
  • 5Daly RJ, Binder MD, Sutherland RL. Overexpression of the Grb2 gene in human breast cancer cell lines [ J ]. Oncogene, 1994, 9(9) :2723 -2727.
  • 6Tari AM, Lopez-Berestein G. GRB2. a pivotal protein in signal transduction [ J ]. Semin Oncol, 2001, 28 (5 Suppl 16) : 142 - 147.
  • 7Hannon GJ. RNA interference[ J]. Nature, 2002, 418 ( 6894 ) : 244 - 251.
  • 8Feller SM, Tuchscherer G, Voss J. High affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia[ J]. Leuk Lymphoma, 2003, 44(3) :411 -427.
  • 9Lowenstein EJ, Daly R J, Batzer AG, Li W, Margolis B, Lammers R, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling[J]. Cell, 1992, 70(3) :431 -442.
  • 10Sebolt-Leopold JS. Development of anticancer drugs targeting the MAP kinase pathway [ J ]. Oncogene, 2000, 19(56) :6594 - 6599.

二级参考文献9

  • 1Klejman A,Schreiner SJ,Nieborowska-Skorska M,et al.The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells[J].EMBO J,2002,21(21):5766-5774.
  • 2Ahonen TJ,Xie JW,Lebaron MJ,et al.Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells[J].Biol Chem,2003,278(29):27287-27292.
  • 3Leong PL,Xi SC,Drenning SD,et al.Differential function of STAT5 isoforms in head and neck cancer growth control[J].Oncogene,2002,21(18):2846-2853.
  • 4Polakis P,Hart M,Rubinfeld B.Defects in the regulation of β-catenin in colorectal cancer[J].Adv Exp Med Biol,1999,470(1):23-32.
  • 5Bwettner R,Mora LB,Jove R.Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention[J].Clin Cancer Res,2002,8(4):945-954.
  • 6Yamada Y,Oyama T,Hirose Y,et al.Beta-catenin mutation is selected during malignant transformation in colon carcinogenesis[J].Carcinogenesis,2003,24(1):91-97.
  • 7Calo V,Nligliavacca M,Bazan V,et al.Stat proteins:from normal control of cellular events to tumorigenesis[J].Cell Physiol,2003,197(2):157-168.
  • 8Julkunen K,Makinen K,Karja V,et al.alpha-,beta-and chiβ-catenin expression in human pancreatic cancer[J].Anticancer Res,2003,23(6D):5043-5047.
  • 9Darnell JE.STATs and gene regulation[J].Science,1997,277(5332):1630-1633.

共引文献3

同被引文献61

  • 1薛凤霞,焦书竹,王海燕,陈斌其.子宫内膜癌ras及HER-2/neu癌基因的表达[J].中华妇产科杂志,1997,32(2):110-110. 被引量:1
  • 2Simon JA, Schreiber SL. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions [J]. Chem Biol, 1995, 2(1): 53-60.
  • 3Pawson T, Saxton TM. Signaling networks-do all roads lead to the same genes[J]. Cell, 1999, 97(6): 675-678.
  • 4Lee JT Jr, McCubrey JA. The Raf/MEK/ERK signal transduetion cascade as a target for chemotherapeutic intervention in leukemia [J]. Leukemia, 2002, 16(4): 486-507.
  • 5Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more[J]. Nat Rev Mol Cell Biol, 2003, 4(12): 915-925.
  • 6Feller SM, Tuchscherer G, Voss J. High affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia[J]. Leuk Lymphoma, 2003, 44(3): 411-427.
  • 7Gishizky ML, Cortez D, Pendergast AM. Mutant forms of growth factor-binding protein-2 reverse bcr-abl induced transformation [J]. Proc Natl Acad Sci USA, 1995, 92(24): 10889-10893.
  • 8Kardinal C, Konkol B, Lin H, et al. Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SOS complexes[J]. Blood, 2001, 98(6): 1773-1781.
  • 9Verbeek BS, ADRIAANSEN-SLOT SS, RIJKSEN G, et al. Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens[J]. J Pathol, 1997, 183(2): 195-203.
  • 10Daly R J, Binder MD, Sutherland RL. Overexpression of the Grb2 gene in human breast cancer cell lines [J]. Oncogene, 1994, 9 (9): 2723-2727.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部